Phase I and Pharmacokinetics Study of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2014
At a glance
- Drugs Lapatinib (Primary) ; Sorafenib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 01 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Dec 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 30 Sep 2009 New trial record